공시 • Dec 31
Enphys Acquisition Corp. Units, Each Consisting of One Class A Ordinary Share and One-Half of One Redeemable Warrant Deleted from OTC Equity Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant has been deleted from OTC Equity effective December 30, 2024, due to Unit Separation. 공시 • Nov 15
Enphys Acquisition Corp. Files Form 15 Enphys Acquisition Corp. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its Units, each consisting of one Class A ordinary share, and one-half of one redeemable warrant; Class A ordinary shares included as part of the Units, par value $0.0001 per share and Redeemable warrants included as part of the Units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share under the Securities Exchange Act of 1934, as amended. 공시 • Oct 17
The Staff of NYSE Regulation Files Form 25 with the SEC to Remove Enphys Acquisition's Class A Ordinary Shares, Units from Listing and Registration on the New York Stock Exchange As previously reported by Enphys Acquisition Corp. (the ‘Company’), on July 24, 2024, the staff of NYSE Regulation (the ‘Staff’), on behalf of the New York Stock Exchange (‘NYSE’), commenced proceedings to delist the Company’s Class A ordinary shares, par value $0.0001 per share (‘Class A Ordinary Shares’), units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant (the ‘Units’), with each warrant exercisable for one share of Class A Ordinary Share of the Company (the ‘Warrants’), and Warrants from the NYSE pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s continued listing standard requiring a listed acquisition company to maintain an average aggregate global market capitalization attributable to its publicly-held shares over a consecutive 30 trading day period of at least $40,000,000. Trading in the Class A Ordinary Shares, Units, and Warrants on the NYSE was suspended after the market closed on July 24, 2024. Effective as of and since July 25, 2024, the Class A Ordinary Shares, Units, and Warrants have been quoted and traded on the OTC Pink Marketplace under the ticker symbols ‘NFSCF,’ ‘NFSUF,’ and ‘NFSWF,’ respectively. The Company timely exercised its right to a review of the Staff’s determination by a committee (the ‘Committee’) of the Board of Directors of the NYSE. On October 10, 2024, the Company withdrew its request for review by the Committee. On October 10, 2024, the Staff filed a Form 25 with the Securities and Exchange Commission (the ‘SEC’) to remove the Company’s Class A Ordinary Shares, Units, and Warrants from listing and registration on the NYSE. The delisting will be effective 10 days following the date of filing of the Form 25. The Company’s Class A Ordinary Shares, Units, and Warrants will continue to trade on the OTC Pink Marketplace following the delisting. 공시 • Aug 14
Enphys Acquisition Corp. announced delayed 10-Q filing On 08/13/2024, Enphys Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. 공시 • Jul 26
NYSE to Commence Delisting Proceedings Against Enphys Acquisition The New York Stock Exchange LLC announced that the staff of NYSE Regulation has determined to commence proceedings to delist Class A ordinary shares, par value 0.0001 per share; Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant and Redeemable warrants, each whole warrant exercisable for one share of Class A ordinary shares at an exercise price of 11.50 of Enphys Acquisition Corp. (the “Company”) from the NYSE. Trading in the Company’s Securities will be suspended immediately. NYSE Regulation reached its decision to delist the Company’s Securities pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s continued listing standard requiring a listed acquisition company to maintain an average aggregate global market capitalization attributable to its publicly-held shares over a consecutive 30 trading day period of at least $40,000,000. The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the Company’s Securities upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision. 공시 • May 17
Enphys Acquisition Corp. announced delayed 10-Q filing On 05/15/2024, Enphys Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. 공시 • Apr 02
Enphys Acquisition Corp. announced delayed annual 10-K filing On 04/01/2024, Enphys Acquisition Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC. 공시 • Nov 17
Enphys Acquisition Corp. announced delayed 10-Q filing On 11/15/2023, Enphys Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. 공시 • Oct 31
Enphys Acquisition Corp. announced that it has received $0.3 million in funding Enphys Acquisition Corp. announced a private placement of non-convertible promissory note to Enphys Acquisition Sponsor LLC in the principal amount of $300,000 on October 30, 2023. The issuance of the Promissory Note was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended. Under the terms of the promissory note, the company may request from time to time prior to the maturity date, up to $300,000 in drawdowns on the principal. Each drawdown request must state the amount to be drawn down, and must not be an amount less than $10,000 unless agreed upon by the company and the payee. Payee shall fund each drawdown request no later than (3) business days after receipt of a drawdown request; provided, however, that the maximum amount of drawdowns outstanding under the promissory note at any time may not exceed $300,000. No fees, payments or other amounts shall be due to the payee in connection with, or as a result of, any drawdown request by the company. 공시 • Oct 11
Enphys Acquisition Corp. announced that it expects to receive $0.4 million in funding Enphys Acquisition Corp. announced a private placement of non-convertible promissory note to Enphys Acquisition Sponsor LLC in the principal amount of $400,000 on October 10, 2023. Payee or one or more of its affiliates or designees will deposit into the company’s trust account established in connection with its initial public offering an amount equal to the lesser of $0.025 per Class A ordinary share of the company multiplied by the number of Class A ordinary shares of the Company then outstanding and $100,000, for each calendar month until the earlier of the company’s completion of a business combination and February 8, 2024. No interest shall be payable on this note. 공시 • May 16
Enphys Acquisition Corp. announced delayed 10-Q filing On 05/15/2023, Enphys Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.